NEFL and early-onset autosomal dominant Alzheimer disease: NF-L levels have been reported to be elevated in the cerebrospinal fluid (CSF) and blood of patients with synucleinopathies, tauopathies, and Alzheimer’s disease and similar increases can been seen in the CSF and plasma of mouse models of the same diseases (Bacioglu et al., 2016).